Stock Comparison

TOI vs UNH

Oncology Institute Inc vs UnitedHealth Group Inc

The Verdict

TOI takes this one.

Winner
TOI

Oncology Institute Inc

2.9

out of 10

Risk Trap
UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Head-to-Head

$468M

Market Cap

$365.5B
-13.2

P/E Ratio

30.3
-8.0%

Profit Margin

2.7%
-482.6%

Return on Equity

12.4%
25.9

Debt-to-Equity

0.8
Aggressive

Overall Risk

Moderate
2.9

DVR Score

0.3

The Deep Dive

TOI2.9/10

Score Change Explanation: The increase from 18/100 to 29/100 is primarily driven by the reported Q1 2026 earnings, where TOI significantly beat both revenue and EPS consensus estimates ($147.44M vs $142.10M, and -$0.02 vs -$0.07). This positive earnings surprise, along along with the provision of updated FY2026 revenue guidance ($630M-$650M) and a material open-market purchase by a 10% owner (Cher...

Full TOI Analysis
UNH0.3/10

UnitedHealth Group (UNH) remains a robust, high-quality mega-cap in the mature and highly regulated healthcare sector. Q1 2026 adjusted EPS of $7.23, a recent dividend increase to $2.32, and some analyst upgrades (e.g., Truist to $440, Goldman Sachs Conviction Buy) reflect solid operational performance and financial strength. However, these are characteristics of a stable compounder, not a company...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.

New member exclusive offer

Sign up free — members unlock an exclusive 44% off Premium deal